FIELD: chemistry.
SUBSTANCE: invention relates to a novel compound of formula 
where Y is 
or 
or a pharmaceutically acceptable salt thereof.
EFFECT: enabling use in treatment of eye conditions, bowel diseases and hair loss.
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC COMPOUNDS | 2009 |
|
RU2500674C2 |
| SUBSTITUTED CYCLOPENTANES, POSSESSING PROSTAGLANDIN ACTIVITY | 2009 |
|
RU2505530C2 |
| SUBSTITUTED CYCLOPENTANS POSSESSING PROSTAGLANDIN ACTIVITY | 2008 |
|
RU2481339C2 |
| 12-ARYL PROSTAGLANDIN ANALOGUES | 2005 |
|
RU2439055C2 |
| SUBSTITUTED GAMMA-LACTAMES AS THERAPEUTIC AGENTS | 2009 |
|
RU2543379C2 |
| CONJUGATES AND PROSTAGLANDIN DERIVATIVES FOR TREATING GLAUCOMA AND INTRAOCULAR HYPERTENSION | 2015 |
|
RU2712221C2 |
| PARTIAL AND FULL AGONISTS OF ADENOSINE RECEPTORS A | 2003 |
|
RU2340623C2 |
| COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR | 2016 |
|
RU2718917C2 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
